DDX6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.508400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.737600E-01
Normal-vs-Stage2
4.435600E-01
Normal-vs-Stage3
1.729410E-01
Normal-vs-Stage4
5.544400E-01
Stage1-vs-Stage2
8.530800E-01
Stage1-vs-Stage3
1.141360E-01
Stage1-vs-Stage4
3.778600E-01
Stage2-vs-Stage3
2.415800E-01
Stage2-vs-Stage4
3.664800E-01
Stage3-vs-Stage4
9.092000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.464200E-01
Normal-vs-AfricanAmerican
5.874600E-01
Normal-vs-Asian
5.387700E-02
Caucasian-vs-AfricanAmerican
1.335620E-01
Caucasian-vs-Asian
6.232500E-02
AfricanAmerican-vs-Asian
3.216400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.333400E-01
Normal-vs-Female
4.771400E-01
Male-vs-Female
3.880000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.756600E-01
Normal-vs-Age(41-60Yrs)
5.642800E-01
Normal-vs-Age(61-80Yrs)
4.167200E-01
Normal-vs-Age(81-100Yrs)
3.469800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.205200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.971200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.434200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.439870E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.257580E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.617440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.125400E-01
Normal-vs-Daily Drinker
3.410200E-01
Normal-vs-Weekly Drinker
3.592800E-01
Normal-vs-Occasional Drinker
2.273200E-01
Normal-vs-Social Drinker
2.475800E-01
Non Drinker-vs-Daily Drinker
3.002600E-01
Non Drinker-vs-Weekly Drinker
4.924400E-01
Non Drinker-vs-Occasional Drinker
2.889600E-01
Non Drinker-vs-Social Drinker
2.781600E-01
Daily Drinker-vs-Weekly Drinker
8.262600E-01
Daily Drinker-vs-Occasional Drinker
6.855900E-02
Daily Drinker-vs-Social Drinker
6.774500E-02
Weekly Drinker-vs-Occasional Drinker
1.514000E-01
Weekly Drinker-vs-Social Drinker
1.424360E-01
Occasional Drinker-vs-Social Drinker
9.567400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
6.237600E-02
Normal-vs-Grade 2
6.536800E-03
Normal-vs-Grade 3
3.235700E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.125000E-01
Grade 1-vs-Grade 3
4.443400E-01
Grade 1-vs-Grade 4
6.237600E-02
Grade 2-vs-Grade 3
6.530000E-01
Grade 2-vs-Grade 4
6.536800E-03
Grade 3-vs-Grade 4
3.235700E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.094800E-01
Normal-vs-NonDiabetic
4.322000E-01
Diabetic-vs-NonDiabetic
6.482000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.416200E-01
Normal-vs-NoPancreatitis
4.342400E-01
Pancreatitis-vs-NoPancreatitis
9.656800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.769000E-01
Normal-vs-N1
4.517200E-01
N0-vs-N1
6.863800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.680200E-01
Normal-vs-TP53-NonMutant
2.201800E-01
TP53-Mutant-vs-TP53-NonMutant
5.824400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
